Percutaneous closure is a viable therapeutic method for coronary artery fistulas, offering an alternative to traditional surgery.
May expand options for coronary fistulas; leaves open need for randomized comparisons with surgery.
Coronary artery fistula (CAF) is the most common hemodynamically significant congenital coronary anomaly. Blood is shunted from the coronary artery to a cardiac chamber, vein or intrathoracic vessel, bypassing the myocardial capillary network. The majority of the fistulas are small, and are detected incidentally and do not require intervention. The natural history of a CAF is variable and even spontaneous closure may be detected in rare cases. Treatment of CAF is indicated for symptomatic patients and for those asymptomatic patients with significant shunt or large fistulas that create risk for future complications, such as infective endocarditis, pulmonary hypertension or heart failure. Traditionally, surgery has been the main therapeutic method for the closure of CAF with proven efficacy and safety. However, since the first report of the use of percutaneous intervention in CAFs, many investigators have reported successful results using several techniques. Recent developments in the percutaneous closure m...
No takes yet. Share an insight, caveat, or question.
Oto et al. (2011) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: